- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04906265
Rehab After Hip Fracture With Wearable Device
January 22, 2024 updated by: Eva Ekvall-Hansson, Lund University
Assessing the Outcome of Rehabilitation After Hip Fracture With a Wearable Device
A randomized control trial, including two intervention arms with different methods for rehabilitation after hip fracture, conducted among persons with the need of rehabilitation in their own home.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The increase of the aging population challenges health care providers.
Fragility, oste-oporosis, and impaired balance are some major risk factors for hip fracture, an injury causing morbidity, mortality, and loss of independent life.
This study aims to study if adding continuous measures of body positions and movements 24 hours a day with an Inertial Measurement Unit (IMU) can, compared to standard rehabilitation alone, optimize rehabilitation after hip fracture.
The study is designed as a randomized controlled trial.
Patients with hip fracture that require rehabilitation at home, will be invited to participate in the study.
Those who accept to participate will randomly be assigned to intervention- or control group.
The intervention comprises standard rehabilitation and continuous measures of body positions and movements 24 hours a day with an IMU.
Standard rehabilitation comprises of home-visits by a PT, where an individualized rehabilitation plan is outlined together with the patient.
The plan includes individually tailored functional exercises.
The plan also includes individually tailored walking exercises, indoor and outdoor when possible.
At each home visit, the PT provides feedback to the participant based on the data from the IMU, i.e. body positions (time spent in sitting, standing, lying down) and body movements (steps per day, step length, walking speed, sideway deviation during walking).
The control group receives standard rehabilitation only.
The primary outcome is balance, in terms of postural sway measured with the IMU, and functional balance measured with the Functional Balance test for Geriatric patients, secondary outcomes are health-related quality of life, measured with the EQ5D, functional independence in everyday activities, measured with the Barthel Index, fear of falling, measured with the Falls Efficacy Scale International, satisfaction with rehabilitation, measured with a single question, and compliance to the intervention .
Study Type
Interventional
Enrollment (Estimated)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Eva Ekvall Hansson, Professor
- Phone Number: +46462221986
- Email: eva.ekvall-hansson@med.lu.se
Study Contact Backup
- Name: Agneta Malmgren Fänge, A professor
- Email: agneta.malmgren_fange@med.lu.se
Study Locations
-
-
-
Malmö, Sweden, SE 211142
- Recruiting
- Community Rehabilitation
-
Contact:
- Åsa Hallén, Manager
- Phone Number: +46702-075028
- Email: asa.hallen@malmo.se
-
Contact:
- Marie Runström, Coordinator
- Phone Number: +46721-739545
- Email: marie.runstrom@malmo.se
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- patients with a hip fracture, living in Malmö, and who are unable to visit a rehabilitation facility and therefore request treatment at home. Another inclusion criterion is the ability to read and understand the Swedish language or the ability to understand information through an interpreter.
Exclusion Criteria:
- the presence of major neurological diseases that have an impact on balance and walk-ing ability; a diagnosed cognitive disease, or moderate to severe cognitive impairment as assessed by a physiotherapist
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control
Standard rehabilitation alone
|
Standard rehabiliation
|
|
Active Comparator: Intervention
The intervention comprises of standard rehabilitation and continuous measures of body positions and movements 24 hour a day with an IMU.
Standard rehabilitation comprises of home-visits by a PT, where an individualized rehabilitation plan is outlined together with the patient.
The plan includes individually tailored functional exercises.
The plan also includes individually tailored walking exercises, indoor and outdoor when possible.
At each home visit, the PT provides feedback to the participant based on the data from the IMU, i.e. body positions (time spent in sitting, standing, lying down) and body movements (steps per day, step length, walking speed).
|
The intervention comprises of standard rehabilitation and continuous measures of body positions and movements 24 hour a day with an IMU.
Standard rehabilitation comprises of home-visits by a PT, where an individualized rehabilitation plan is outlined together with the patient.
The plan includes individually tailored functional exercises.
The plan also includes individually tailored walking exercises, indoor and outdoor when possible.
At each home visit, the PT provides feedback to the participant based on the data from the IMU, i.e. body positions (time spent in sitting, standing, lying down) and body movements (steps per day, step length, walking speed, sideway deviation during walking)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in postural sway
Time Frame: Baseline, through study completion, on average 3 months
|
Medio-lateral and anterior-posterior sway measured with the IMU in mm/sec
|
Baseline, through study completion, on average 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in functional independence i everyday activities
Time Frame: Baseline and after study completion, on average 3 months
|
The Barthel Index, likert scale, 6 items graded 0, 5, 10, 2 items graded 0, 5 and 2 items graded 0, 5, 10, 15. 100 highest possible score (best)
|
Baseline and after study completion, on average 3 months
|
|
Change in health-related quality of life
Time Frame: Baseline and after study completion, on average 3 months
|
EQ5D visual analogue scale, graded from 0 (worst health) to 100 (best health)
|
Baseline and after study completion, on average 3 months
|
|
Change in function
Time Frame: Baseline and after study completion, on average 3 months
|
EQ5D5L index from 0 (dead) to 1 (best imaginable health)
|
Baseline and after study completion, on average 3 months
|
|
Change in functional balance
Time Frame: Baseline and after study completion, on average 3 months
|
the Functional Balance test for Geriatric patients, including 4 tasks graded between 0-6,
|
Baseline and after study completion, on average 3 months
|
|
Change in fear of falling
Time Frame: Baseline and after study completion, on average 3 months
|
the Falls Efficacy Scale International , (22), comprising 16 questions with four possible answers
|
Baseline and after study completion, on average 3 months
|
|
Satisfaction with rehabilitation
Time Frame: After study completion, on average 3 months
|
Measured with a single question if the person thinks their need of rehabilitation is provided for, with four possible answers
|
After study completion, on average 3 months
|
|
Compliance to the intervention
Time Frame: Through study completion, on average 3 months
|
Measured with a single question on how much the participant has trained since the last home visit, with three possible answers
|
Through study completion, on average 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Eva Ekvall Hansson, Lund University, Medical Faculty, Dep of Health Sciences
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2021
Primary Completion (Estimated)
June 30, 2025
Study Completion (Estimated)
December 31, 2025
Study Registration Dates
First Submitted
May 7, 2021
First Submitted That Met QC Criteria
May 24, 2021
First Posted (Actual)
May 28, 2021
Study Record Updates
Last Update Posted (Estimated)
January 24, 2024
Last Update Submitted That Met QC Criteria
January 22, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020-00789
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Charing individual data is not aloud according to Swedish law
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fracture of Hip
-
Cukurova UniversityCompleted
-
Milton S. Hershey Medical CenterWithdrawnPertrochanteric Fracture of Femur, Closed
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingHip Fractures | Pathological Fracture | Pathological Fracture of Hip | Hip Fracture PathologicUnited States
-
Aesculap AGRecruitingRevision Total Hip Arthroplasty | Periprosthetic Fracture of HipUnited Kingdom, Germany
-
Hvidovre University HospitalCompleted
-
Brno University HospitalSt. Anne's University Hospital Brno, Czech RepublicCompletedFracture of Neck of Femur (Hip)Czech Republic
-
AO Clinical Investigation and Publishing DocumentationCompletedHip Fractures | Closed Fracture of HipIsrael, Austria, Switzerland, Germany, Belgium, Norway
-
Diego Matías Domínguez PradoRecruitingHip Fracture of Intertrochanteric TypeSpain
-
Odense University HospitalCompletedHip Fracture of Intertrochanteric TypeDenmark
-
Michal Roll PhD,MBATel-Aviv Sourasky Medical CenterUnknown
Clinical Trials on Intervention
-
Biolux Research Holdings, Inc.TerminatedOrthodontic Tooth MovementCanada
-
Nottingham Trent UniversityUnknownOverweight and ObesityUnited Kingdom
-
University of California, San FranciscoNational Cancer Institute (NCI)CompletedColorectal Carcinoma | Healthy Subject | Health Status UnknownUnited States
-
University of Southern DenmarkTrygFonden, DenmarkUnknownObesity | Overweight | Metabolic Syndrome | ChildrenDenmark
-
University of FloridaCompletedSensitivityUnited States
-
Ohio State University Comprehensive Cancer CenterCompleted
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnCancer Survivor | Peripheral Sensory Neuropathy
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedStage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8United States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...American Cancer Society, Inc.Completed
-
Vanderbilt UniversityAgency for Healthcare Research and Quality (AHRQ)Completed